Autonomix Medical (AMIX) Stock Price, News & Analysis

Company Overview

Autonomix Medical, Inc., a development stage medical device development company, focuses on advancing technologies for sensing and treating disorders relating to the peripheral nervous system. Its technology platform includes a catheter-based microchip-enabled sensing array to detect and differentiate peripheral neural signals. The company was incorporated in 2014 and is based in The Woodlands, Texas.

Key Stats

• Today's Range: $0.66 to $0.80
• 50-Day Range: $0.53 to $1.54
• 52-Week Range: $0.51 to $7.60
• Volume: 438,204 shs
• Average Volume: 1.93 million shs
• Market Capitalization: $13.34 million
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: $1.40
• Consensus Rating: Buy

Autonomix Medical Stock Analysis - MarketRank™

Autonomix Medical scored higher than 41% of companies evaluated by MarketBeat, and ranked 710th out of 995 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

Analyst's Opinion

• Score: 3.5 / 5
• Analyst Rating: Buy

Consensus Rating

Autonomix Medical has received a consensus rating of Buy. The company's average rating score is 3.00, and is based on 1 buy rating, no hold ratings, and no sell ratings.

Amount of Analyst Coverage

Autonomix Medical has only been the subject of 1 research reports in the past 90 days.

Earnings and Valuation

• Score: 0.0 / 5
• Proj. Earnings Growth: Decreasing

Earnings Growth

Earnings for Autonomix Medical are expected to decrease in the coming year, from ($0.50) to ($0.53) per share.

Price to Book Value per Share Ratio

Autonomix Medical has a P/B Ratio of 1.60. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.

Short Interest

• Score: 3.0 / 5
• Short Interest Level: Healthy

Percentage of Shares Shorted

1.58% of the float of Autonomix Medical has been sold short.

Short Interest Ratio / Days to Cover

Autonomix Medical has a short interest ratio ("days to cover") of 0, which is generally considered an acceptable ratio of short interest to trading volume.

Change versus previous month

Short interest in Autonomix Medical has recently increased by 64.98%, indicating that investor sentiment is decreasing significantly.

Dividend

• Score: 0.0 / 5
• Dividend Strength: N/A

Dividend Yield

Autonomix Medical does not currently pay a dividend.

Dividend Growth

Autonomix Medical does not have a long track record of dividend growth.

Sustainability and ESG

• Score: N/A
• Environmental Score: N/A

Percentage of Shares Shorted

1.58% of the float of Autonomix Medical has been sold short.

Short Interest Ratio / Days to Cover

Autonomix Medical has a short interest ratio ("days to cover") of 0, which is generally considered an acceptable ratio of short interest to trading volume.

Change versus previous month

Short interest in Autonomix Medical has recently increased by 64.98%, indicating that investor sentiment is decreasing significantly.

News and Social Media

• Score: 2.7 / 5
• News Sentiment: N/A

News Sentiment

Autonomix Medical has a news sentiment score of 1.89. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.67 average news sentiment score of Medical companies.

News Coverage This Week

MarketBeat has tracked 1 news article for Autonomix Medical this week, compared to 1 article on an average week.

Search Interest

Only 2 people have searched for AMIX on MarketBeat in the last 30 days. This is a decrease of -80% compared to the previous 30 days.

Company Ownership

• Score: 0.0 / 5
• Insider Trading: N/A

Insider Buying vs. Insider Selling

In the past three months, Autonomix Medical insiders have not sold or bought any company stock.

Percentage Held by Institutions

Only 10.78% of the stock of Autonomix Medical is held by institutions.

AMIX Stock Analysis - Frequently Asked Questions

How have AMIX shares performed this year?

Autonomix Medical's stock was trading at $5.20 at the beginning of 2024. Since then, AMIX shares have decreased by 87.4% and is now trading at $0.6565.
View the best growth stocks for 2024 here.

How were Autonomix Medical's earnings last quarter?

Autonomix Medical, Inc. (NASDAQ:AMIX) posted its quarterly earnings data on Tuesday, August, 13th. The company reported ($0.14) earnings per share (EPS) for the quarter.

When did Autonomix Medical IPO?

Autonomix Medical (AMIX) raised $11 million in an IPO on the week of January 29th 2024. The company issued 2,234,222 shares at a price of $5.00 per share.

When did Autonomix Medical's lock-up period expire?

Autonomix Medical's lock-up period expired on Monday, July 29th. Autonomix Medical had issued 2,234,222 shares in its public offering on January 29th. The total size of the offering was $11,171,110 based on an initial share price of $5.00. Since the end of Autonomix Medical's lock-up period, restrictions preventing company insiders and major shareholders from selling shares in the company have been lifted.

How do I buy shares of Autonomix Medical?

Shares of AMIX stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

Company Calendar

• Last Earnings: 8/13/2024
• Today: 9/17/2024
• Fiscal Year End: 3/31/2025

Industry, Sector and Symbol

• Stock Exchange: NASDAQ
• Sector: Medical
• Industry: Surgical & medical instruments
• Sub-Industry: Medical Equipment
• Current Symbol: NASDAQ:AMIX
• Previous Symbol: NASDAQ:AMIX
• CUSIP: N/A
• CIK: 1617867
• Web: autonomix.com
• Phone: 713-588-6150
• Fax: N/A
• Employees: 1
• Year Founded: N/A

Price Target and Rating

• Average Stock Price Target: $1.40
• High Stock Price Target: $1.40
• Low Stock Price Target: $1.40
• Potential Upside/Downside: +113.3%
• Consensus Rating: Buy
• Rating Score (0-4): 3.00
• Research Coverage: 1 Analysts

Profitability

• EPS (Most Recent Fiscal Year): N/A
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: N/A
• Net Margins: N/A
• Pretax Margin: N/A
• Return on Equity: N/A
• Return on Assets: N/A

Debt

• Debt-to-Equity Ratio: 0.20
• Current Ratio: 9.27
• Quick Ratio: 9.27

Sales & Book Value

• Annual Sales: N/A
• Price / Sales: N/A
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: $0.41 per share
• Price / Book: 1.60

Miscellaneous

• Outstanding Shares: 18,845,000
• Free Float: N/A
• Market Cap: $12.37 million
• Optionable: N/A
• Beta: N/A